Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
(NASDAQ: PSNL) Delayed: 10.17 -0.37 (3.51%)
Previous Close $10.54    52 Week High $ 
Open $10.49    52 Week Low $ 
Day High $10.86    P/E N/A 
Day Low $9.65    EPS $ 
Volume 2,506,301